On-Demand Webinars

  1. Flexible Therapeutic Development: Balancing Speed, Cost, and Process 3/24/2026

    Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.

  2. Reducing Risk, Enhancing Flexibility: A New Approach To Custom Media Manufacturing 3/20/2026

    The session highlights how tailored media solutions, combined with strong scientific understanding and scalable manufacturing practices, can support more efficient, reliable, and future-ready bioprocess development.

  3. Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development 3/19/2026

    Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.

  4. Quality Assurance In Pharmaceutical Water For Injection (WFI) Systems 3/19/2026

    Maintaining the integrity of Water for Injection (WFI) systems is a non-negotiable priority in pharmaceutical manufacturing. Watch this webinar to refine your contamination control strategies.

  5. How AI-Enabled Validation Technologies Enable The Predictive Plant 3/18/2026

    Discover how AI-enabled digital validation shifts manufacturers from reactive compliance to predictive intelligence, connecting validation, asset, and quality data to accelerate digital maturity.

  6. Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems 3/18/2026

    Learn how optimized expression vector design and data-driven strategies can significantly enhance product titre, quality, and long-term gene expression stability in GS-CHO cell-based manufacturing.

  7. Strategies For Robust Process Characterization And Validation To Accelerate Biologics Manufacturing 3/8/2026

    Uncover how data-driven process design, effective technology transfer, and robust process characterization can accelerate validation readiness and help move biologics from development to commercial success faster.

  8. Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies 3/4/2026

    Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

  9. Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right 3/3/2026

    This session highlights common late-stage risks and discusses how a stronger stability design can support confident IND, BLA, and long-term supply strategies.

  10. USP <665> Compliance Guidance 2/26/2026

    Experts address key USP <665> questions, including risk assessment, testing approaches, extractables and leachables, and practical challenges in implementing single‑use systems in manufacturing.